BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31312216)

  • 1. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan.
    Chou JW; Lai HC; Chang CH; Cheng KS; Feng CL; Chen TW
    Gastroenterol Res Pract; 2019; 2019():4175923. PubMed ID: 31312216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia.
    Al-Fawzan AA; Al-Radhi SA; Al-Omar AS; Al-Mutiri NH; Al-Ammari AM; El-Gohary M; Shamsan AN; Al Shehri HM; ALGhasab NS
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.
    Niriella MA; Liyanage IK; Kodisinghe SK; De Silva AP; Jayatissa AVGAM; Navarathne NMM; Peiris RK; Kalubovila UP; Kumarasena SR; Jayasekara RW; de Silva HJ
    BMC Gastroenterol; 2021 Feb; 21(1):71. PubMed ID: 33593289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
    Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V
    Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Fedor I; Zold E; Barta Z
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
    J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior.
    Banerjee R; Pal P; Hutfless S; Ganesh BG; Reddy DN
    Intest Res; 2019 Oct; 17(4):486-495. PubMed ID: 31370386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients.
    Adam H; Alqassas M; Saadah OI; Mosli M
    J Epidemiol Glob Health; 2020 Dec; 10(4):298-303. PubMed ID: 32959603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
    Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
    Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias].
    Saro Gismera C; Lacort Fernández M; Argüelles Fernández G; Antón Magarzo J; Navascues CA; Garcia López R; Suárez González A; Diaz Alvarez G; Palacios Galán A; Altadill arregui A; Vizoso F; González Bernal A; Martínez A
    Gastroenterol Hepatol; 2001 May; 24(5):228-35. PubMed ID: 11412590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].
    Guan DX; Yu FH; Wang GL; Zhou J; Wang DY; Nie XL; Xu XW
    Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):493-498. PubMed ID: 28728256
    [No Abstract]   [Full Text] [Related]  

  • 17. Current trends in inflammatory bowel disease: the natural history.
    Langholz E
    Therap Adv Gastroenterol; 2010 Mar; 3(2):77-86. PubMed ID: 21180592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and clinical course of inflammatory bowel disease in the Central Province of Sri Lanka: A hospital-based study.
    Kalubowila U; Liyanaarachchi T; Galketiya KB; Rathnayaka P; Piyasena INAP; Tennakoon S; Perera KMP; Pathirana SDMU; Wettewa DB; Ratnayake WRANMP; Raayiz RM; Dissanayaka DMIU
    JGH Open; 2018 Aug; 2(4):129-133. PubMed ID: 30483577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.